BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3746815)

  • 21. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes.
    Hoyer D; Vos P; Closse A; Pazos A; Palacios JM; Davies H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):226-30. PubMed ID: 2884572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
    López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
    Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
    Wenk GL; Engisch KL
    J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and localization of serotonin receptors in human brain postmortem.
    Biegon A; Kargman S; Snyder L; McEwen BS
    Brain Res; 1986 Jan; 363(1):91-8. PubMed ID: 2936426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of serotonin binding sites on human platelets.
    McBride PA; Mann JJ; McEwen B; Biegon A
    Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
    Leysen JE; Gommeren W; De Clerck F
    Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7-Amino-8-[125I]-ketanserin ([125I]AMIK), a highly sensitive, serotonin-S2 receptor ligand.
    Wouters W; Van Dun J; Laduron PM
    Biochem Pharmacol; 1986 Oct; 35(19):3199-202. PubMed ID: 3768016
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of brain S2 serotonin receptors by lithium, sodium and potassium chloride.
    Battaglia G; Shannon M; Titeler M
    Life Sci; 1983 May; 32(22):2597-601. PubMed ID: 6304441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.
    Johnson MP; Siegel BW; Carr AA
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):205-9. PubMed ID: 8857599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha 1 adrenergic receptors in the porcine pituitary neurointermediate lobe: detection with [3H]ketanserin.
    Battaglia G; Shannon M; Borgundvaag B; Titeler M
    J Recept Res; 1984; 4(7):713-26. PubMed ID: 6098679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubilized serotonin receptors from rat and dog brain. Selective labelling with [3H]ketanserin.
    Ilien B; Schotte A; Laduron PM
    FEBS Lett; 1982 Feb; 138(2):311-5. PubMed ID: 6121721
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
    Laruelle M; Vanisberg MA; Maloteaux JM
    Biol Psychiatry; 1988 Jul; 24(3):299-309. PubMed ID: 2969755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin-S2 receptor binding sites and functional correlates.
    Leysen JE; de Chaffoy de Courcelles D; De Clerck F; Niemegeers CJ; Van Nueten JM
    Neuropharmacology; 1984 Dec; 23(12B):1493-501. PubMed ID: 6396526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region.
    Altar CA; Boyar WC; Marien MR
    Brain Res; 1986 Apr; 372(1):130-6. PubMed ID: 2423187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.